Pages that link to "Q41886690"
Jump to navigation
Jump to search
The following pages link to Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males (Q41886690):
Displaying 19 items.
- Potential role of dipeptidyl peptidase IV in the pathophysiology of heart failure (Q26829634) (← links)
- INTERACTING DISCIPLINES: Cardiac natriuretic peptides and obesity: perspectives from an endocrinologist and a cardiologist (Q28083473) (← links)
- GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond. (Q36406821) (← links)
- Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure (Q36454284) (← links)
- Effects of GLP-1 in the kidney (Q38208950) (← links)
- Intestinal regulation of urinary sodium excretion and the pathophysiology of diabetic kidney disease: a focus on glucagon-like peptide 1 and dipeptidyl peptidase 4. (Q38236209) (← links)
- Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes--focus on pancreatitis and pancreas cancer (Q38264360) (← links)
- Mechanisms for the cardiovascular effects of glucagon-like peptide-1. (Q38589032) (← links)
- GLP-1 Agonists and Blood Pressure: A Review of the Evidence. (Q38709406) (← links)
- Cardiovascular safety and benefits of GLP-1 receptor agonists (Q39013056) (← links)
- The physiological role of glucagon-like peptide-1 in the regulation of renal function (Q40976120) (← links)
- Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS. (Q49359455) (← links)
- GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes (Q50225916) (← links)
- Early 24-hour blood pressure response to Roux-en-Y gastric bypass in obese patients. (Q51034517) (← links)
- Effects of exogenous glucagon-like peptide-1 on blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in older individuals with normal glucose tolerance or type 2 diabetes. (Q53215510) (← links)
- Renal extraction and acute effects of glucagon-like peptide-1 on central and renal hemodynamics in healthy men (Q58167460) (← links)
- Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial (Q58447382) (← links)
- Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function (Q59812434) (← links)
- Glucagon-Like Peptide 1 and Atrial Natriuretic Peptide in a Female Mouse Model of Obstructive Pulmonary Disease (Q89498806) (← links)